These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31206195)

  • 21. Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition.
    Dandri M; Bertoletti A; Lütgehetmann M
    Semin Immunopathol; 2021 Aug; 43(4):535-548. PubMed ID: 34019142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity.
    Groth C; Maric J; Garcés Lázaro I; Hofman T; Zhang Z; Ni Y; Keller F; Seufert I; Hofmann M; Neumann-Haefelin C; Sticht C; Rippe K; Urban S; Cerwenka A
    Front Immunol; 2023; 14():1287367. PubMed ID: 38143742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Hepatitis B Virus Infection Induces Cytopathic Effects in Primary Human Hepatocytes, and Can Be Partially Reversed by Antiviral Therapy.
    Zai W; Hu K; Ye J; Ding J; Huang C; Li Y; Fang Z; Wu M; Wang C; Chen J; Yuan Z
    Microbiol Spectr; 2022 Feb; 10(1):e0132821. PubMed ID: 35171034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.
    Oberhardt V; Hofmann M; Thimme R; Neumann-Haefelin C
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.
    Engle RE; De Battista D; Danoff EJ; Nguyen H; Chen Z; Lusso P; Purcell RH; Farci P
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes.
    Lange F; Garn J; Anagho HA; Vondran FWR; von Hahn T; Pietschmann T; Carpentier A
    Liver Int; 2023 Oct; 43(10):2116-2129. PubMed ID: 37366005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection.
    Palatini M; Müller SF; Kirstgen M; Leiting S; Lehmann F; Soppa L; Goldmann N; Müller C; Lowjaga KAAT; Alber J; Ciarimboli G; Ziebuhr J; Glebe D; Geyer J
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
    Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
    Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.
    Lucifora J; Alfaiate D; Pons C; Michelet M; Ramirez R; Fusil F; Amirache F; Rossi A; Legrand AF; Charles E; Vegna S; Farhat R; Rivoire M; Passot G; Gadot N; Testoni B; Bach C; Baumert TF; Hyrina A; Beran RK; Zoulim F; Boonstra A; Büning H; Verrier ER; Cosset FL; Fletcher SP; Salvetti A; Durantel D
    J Hepatol; 2023 May; 78(5):958-970. PubMed ID: 36702177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
    Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
    J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
    Zhang Z; Urban S
    J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.
    Sureau C
    Methods Mol Biol; 2010; 640():463-73. PubMed ID: 20645068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Interactions between HBV and the Innate Immunity of Hepatocytes.
    Megahed FAK; Zhou X; Sun P
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32151000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of host factor networks during hepatitis B virus infection in primary human hepatocytes.
    Hwangbo S; Kim G; Choi Y; Park YK; Bae S; Ryu JY; Hur W
    Virol J; 2024 Aug; 21(1):170. PubMed ID: 39090742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes.
    Barrera A; Guerra B; Lee H; Lanford RE
    J Virol; 2004 May; 78(10):5233-43. PubMed ID: 15113905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity.
    Altstetter SM; Quitt O; Pinci F; Hornung V; Lucko AM; Wisskirchen K; Jung S; Protzer U
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
    Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.
    Woo Y; Ma M; Okawa M; Saito T
    Viruses; 2024 May; 16(5):. PubMed ID: 38793622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.